Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:NTEC

Intec Pharma (NTEC) Stock Price, News & Analysis

Intec Pharma logo

About Intec Pharma Stock (NASDAQ:NTEC)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$9.15
$36.20
52-Week Range
N/A
Volume
988,300 shs
Average Volume
543,436 shs
Market Capitalization
$8.65 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive NTEC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Intec Pharma and its competitors with MarketBeat's FREE daily newsletter.

NTEC Stock News Headlines

Indaptus Therapeutics reports Q3 EPS (32c) vs. (47c) last year
I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
X4 Pharmaceuticals, Inc. (XFOR)
INDP Indaptus Therapeutics, Inc.
See More Headlines

NTEC Stock Analysis - Frequently Asked Questions

Intec Pharma Ltd (NASDAQ:NTEC) announced its quarterly earnings results on Monday, May, 17th. The biotechnology company reported ($3.84) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($3.48) by $0.36.

Intec Pharma's stock reverse split before market open on Tuesday, July 27th 2021.The 1-4 reverse split was announced on Tuesday, July 27th 2021. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, July 27th 2021. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split.

Intec Pharma (NTEC) raised $30 million in an IPO on Tuesday, August 4th 2015. The company issued 5,000,000 shares at a price of $6.00 per share. Maxim Group and Roth Capital Partners served as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Intec Pharma investors own include FuelCell Energy (FCEL), NVIDIA (NVDA), Ovid Therapeutics (OVID), Plug Power (PLUG), SCYNEXIS (SCYX), Fortress Biotech (FBIO) and Lipocine (LPCN).

Company Calendar

Last Earnings
5/17/2021
Today
7/14/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:NTEC
CIK
1638381
Fax
N/A
Employees
40
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($16.32)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$14.13 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-96.37%
Return on Assets
-68.87%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.34
Quick Ratio
2.34

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$16.18 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
898,000
Free Float
N/A
Market Cap
$8.65 million
Optionable
Optionable
Beta
0.83
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (NASDAQ:NTEC) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners